Ng V L, Chen K H, Hwang K M, Khayam-Bashi H, McGrath M S
Department of Medicine, University of California, San Francisco.
Blood. 1989 Nov 15;74(7):2471-5.
We observed and characterized paraproteins present in the serum of seven human immunodeficiency virus type 1 (HIV-1)-infected individuals. Immunoglobulin (Ig) subclass typing performed on these paraproteins identified five as IgG1 kappa, one as an IgG3 lambda, and one as an IgA lambda. The IgG1 kappa paraproteins, purified by high-pressure liquid chromatography, contained the majority of anti-HIV-1 antibody reactivity present in the five serum specimens (ranging from 1:5,000 to 1:500,000) as demonstrated by immunoblot. All five IgG1 paraproteins had at least two light chain species as demonstrated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and the antibodies were reactive with multiple HIV-1 viral antigens. In contrast, the electrophoretically purified IgG3 lambda and IgA lambda paraproteins did not react with HIV-1 antigens and only one light chain species was detected by SDS-PAGE. The subsequent clinical evaluation of these patients following the initial observation of paraproteinemias failed to correlate the presence of paraproteins with the development of lymphoma over a 2 to 3 year period. These data support the hypothesis that IgG1 paraproteins present in the sera of HIV-1 infected individuals reflect a normal albeit exuberant polyclonal immune response to HIV-1 viral antigens. In contrast, the clinical significance of an IgG3 lambda or an IgA lambda paraprotein is unclear at present.
我们观察并鉴定了7名感染1型人类免疫缺陷病毒(HIV-1)个体血清中的副蛋白。对这些副蛋白进行免疫球蛋白(Ig)亚类分型,鉴定出5种为IgG1 κ型,1种为IgG3 λ型,1种为IgA λ型。通过高压液相色谱法纯化的IgG1 κ型副蛋白,包含了5份血清标本中存在的大部分抗HIV-1抗体反应性(范围从1:5,000至1:500,000),免疫印迹法证实了这一点。如十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)所示,所有5种IgG1副蛋白至少有两种轻链类型,并且这些抗体与多种HIV-1病毒抗原发生反应。相比之下,经电泳纯化的IgG3 λ型和IgA λ型副蛋白不与HIV-1抗原反应,并且通过SDS-PAGE仅检测到一种轻链类型。在最初观察到副蛋白血症后,对这些患者进行的后续临床评估未能将副蛋白的存在与2至3年期间淋巴瘤的发生相关联。这些数据支持这样一种假说,即HIV-1感染个体血清中存在的IgG1副蛋白反映了对HIV-1病毒抗原的正常尽管旺盛的多克隆免疫反应。相比之下,目前尚不清楚IgG3 λ型或IgA λ型副蛋白的临床意义。